Epithalon vs NAD+
Evidence-based comparison · Updated 2026
Summary
Epithalon and NAD+ both target aging but through distinct mechanisms. Epithalon is best suited for research focused on telomere biology and pineal-driven circadian regulation, while NAD+ is more broadly studied for mitochondrial energy metabolism, DNA repair, and sirtuin activation. Researchers prioritizing cellular energetics and metabolic function tend toward NAD+; those focused on telomere length and circadian aging lean toward Epithalon.
Side-by-Side Comparison
| Epithalon | NAD+ | |
|---|---|---|
| Evidence | BEvidenceGrade BSmaller human trials, observational studies, or approved in 30+ countries | |
| Regulatory | Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only | |
| Benefits |
|
|
| Dosage | 5-10 mg mg — Daily for 10-20 days | 250-500 mcg — 1-2x daily |
| Route | Subcutaneous, Intramuscular | Subcutaneous |
| Category | Skin & Anti-Aging | Metabolic & Weight Loss |
Which Should You Choose?
Epithalon operates primarily at the level of telomerase activation and pineal gland modulation, while NAD+ functions as a universal redox coenzyme powering mitochondrial metabolism, DNA repair enzymes, and sirtuin-dependent longevity pathways. These two compounds address aging through largely non-overlapping biological targets.
Choose Epithalon when:
- +Research focus is on telomere attrition and cellular replicative aging, where Epithalon's proposed telomerase activation mechanism is directly relevant.
- +Study involves circadian rhythm disruption or melatonin dysregulation, as Epithalon is derived from a pineal gland extract and has been studied for these effects.
- +Interest is in neuroprotective or lifespan-extending mechanisms that are independent of energy substrate availability.
Choose NAD+ when:
- +Research focus centers on mitochondrial dysfunction, metabolic decline, or age-related drops in cellular ATP production, where NAD+ serves as a direct substrate.
- +Study involves DNA damage repair pathways or PARP-dependent genomic stability, both of which depend on NAD+ availability.
- +Interest is in sirtuin activation, metabolic flexibility, or exercise recovery, where NAD+ precursor restoration has a more established research base.
Stacking Epithalon with NAD+ precursors is conceptually plausible in longevity research given their complementary and non-redundant mechanisms, though no published studies have formally evaluated this combination.
Frequently Asked Questions
Do Epithalon and NAD+ work on the same aging pathways, or are they targeting different mechanisms?⌄
Which has a stronger evidence base: Epithalon or NAD+?⌄
Would stacking Epithalon with NAD+ or its precursors offer additive benefits in longevity research?⌄
How do the research timelines and expected effect windows differ between Epithalon and NAD+?⌄
Goal-Based Guides
Broader evidence guides for the goals this comparison relates to.
Not sure which fits your research goals?
Use the Goal Finder
Answer 3 questions and get a personalised peptide recommendation ranked by evidence grade.
Find My Peptide →